MedPath

浙江赛默制药有限公司

Ownership
-
Established
2019-06-12
Employees
-
Market Cap
-
Website
www.cdmopha.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Acetylcysteine Effervescent Tablets

Product Name
乙酰半胱氨酸泡腾片
Approval Number
国药准字H20254174
Approval Date
May 13, 2025
NMPA

Formoterol Fumarate Inhalation Solution

Product Name
富马酸福莫特罗吸入溶液
Approval Number
国药准字H20254059
Approval Date
Apr 30, 2025
NMPA

Nicorandil Tablets

Product Name
尼可地尔片
Approval Number
国药准字H20253120
Approval Date
Jan 8, 2025
NMPA

Acipimox Capsules

Product Name
阿昔莫司胶囊
Approval Number
国药准字H20244607
Approval Date
Jul 30, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.